Page 9 - Reverse Transcriptase News Today

Researchers analyzed the surface swabs for SARS-CoV-2 RNA and the infectivity in a hospital setting by both qRT-PCR and a viral culture assay. They also determined the suitability for sequence analysis and phylogenetically identifying the source of the virus.

Key breakthroughs in the race to rid the world of the virus – and the difficulties that could lie ahead

Researchers at the University of California, San Diego, have demonstrated the potential of using green algae to make recombinant viral proteins that could be used in large scale assays to detect antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

A new preprint appearing on the medRxiv server describes the changes that occur in numerous antibodies and inflammatory molecules with age and at varying stages, or severity, of the infection and resulting illness. The results may help to predict the risk in individual cases.

A new study by researchers in the Netherlands confirms the hypothesis that for SARS-CoV-2 infection, higher age is associated with increased viral loads.

Good morning, members and staff: I am a confirmed positive. I have been tested daily, and yesterday I received notice that my rapid test was positive. I have been made aware of 2 other confirmed positives, and my PCR results came back, confirming my own positive. Please self-isolate for 14 days, as I recommended in both my earlier email and in the written guidance sent to you before returning to Springfield. While I had no symptoms yesterday morning, I did start to show mild symptoms yesterd...

A fast and accurate virus detection strategy is very crucial to reduce the rate of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for COVID-19. The global scientific research community responded to this unprecedented demand in diagnostic testing by developing several detection platforms, the most sensitive of which detect the viral RNA.

KUALA LUMPUR (Dec 23): Insurance and Takaful providers have broadened the eligibility criteria of the Covid-19 Test Fund (CTF) to include all asymptomatic individual and group medical health insurance policy and takaful certificate holders (MHIT) in the country. In a joint statement, the Life Insurance Association of Malaysia (LIAM), Malaysian Takaful Association (MTA) and General Insurance Association of Malaysia (PIAM) said the move was done in view of the spike in Covid-19 cases in the count...